Brivudine ophthalmicAlternative Names: brivudin eye drops; brivudin ophthalmic; brivudine eye drops
Latest Information Update: 16 Jul 2016
At a glance
- Originator Menarini
- Class Adjuvants; Antivirals; Deoxyribonucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors; Thymidylate synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Ophthalmic infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Ophthalmic-infections in Europe (Ophthalmic, Drops)